About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 769042, 7 pages
http://dx.doi.org/10.1155/2012/769042
Research Article

Use of Chinese Herb Medicine in Cancer Patients: A Survey in Southwestern China

1Department of Abdominal Cancer, West China Hospital, Sichuan University, Sichuan Province, Chengdu 610041, China
2Department of Medical Oncology, Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu 610075, China

Received 8 March 2012; Revised 11 June 2012; Accepted 16 July 2012

Academic Editor: Arndt Büssing

Copyright © 2012 Tai-Guo Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Chan, T. H. Lin, V. Shih, T. H. Ching, and J. Chiang, “Clinical outcomes for cancer patients using complementary and alternative medicine,” Alternative Therapies in Health and Medicine, vol. 18, no. 1, pp. 12–17, 2012.
  2. I. Hyodo, N. Amano, K. Eguchi et al., “Nationwide survey on complementary and alternative medicine in cancer patients in Japan,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2645–2654, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. B. Swarup, W. Barrett, and A. R. Jazieh, “The use of complementary and alternative medicine by cancer patients undergoing radiation therapy,” American Journal of Clinical Oncology, vol. 29, no. 5, pp. 468–473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. R. Ezeome and A. N. Anarado, “Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria,” BMC Complementary and Alternative Medicine, vol. 7, article 28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Chen, K. Gu, Y. Zheng, W. Zheng, W. Lu, and X. O. Shu, “The use of complementary and alternative medicine among Chinese women with breast cancer,” Journal of Alternative and Complementary Medicine, vol. 14, no. 8, pp. 1049–1055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Teng, K. Jin, K. He et al., “Use of complementary and alternative medicine by cancer patients at zhejiang university teaching hospital zhuji hospital, China,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 7, no. 4, pp. 322–330, 2010. View at Scopus
  7. B. Patwardhan, D. Warude, P. Pushpangadan, and N. Bhatt, “Ayurveda and traditional Chinese medicine: a comparative overview,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 4, pp. 465–473, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Lukman, Y. He, and S. C. Hui, “Computational methods for Traditional Chinese Medicine: a survey,” Computer Methods and Programs in Biomedicine, vol. 88, no. 3, pp. 283–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Seki, M. Chisaka, M. Eriguchi et al., “An attempt to integrate Western and Chinese medicine: rationale for applying Chinese medicine as chronotherapy against cancer,” Biomedicine and Pharmacotherapy, vol. 59, no. 1, pp. S132–S140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Zhou, Y. Peng, and B. Liu, “Text mining for traditional Chinese medical knowledge discovery: a survey,” Journal of Biomedical Informatics, vol. 43, no. 4, pp. 650–660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Liu and Z. Chen, “Traditional Chinese medicine in the new century,” Frontiers of Medicine, vol. 5, no. 2, pp. 111–114, 2011.
  12. L. Yang, D. M. Parkin, J. Ferlay, L. Li, and Y. Chen, “Estimates of cancer incidence in China for 2000 and projections for 2005,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 1, pp. 243–250, 2005. View at Scopus
  13. P. Zhao, M. Dai, W. Chen, and N. Li, “Cancer trends in China,” Japanese Journal of Clinical Oncology, vol. 40, no. 4, pp. 281–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Shu, M. McCulloch, H. Xiao, M. Broffman, and J. Gao, “Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials,” Integrative Cancer Therapies, vol. 4, no. 3, pp. 219–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. C. S. Cho and H. Y. Chen, “Clinical efficacy of traditional chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis,” Cancer Investigation, vol. 27, no. 3, pp. 334–344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. McCulloch, C. See, X. J. Shu et al., “Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials,” Journal of Clinical Oncology, vol. 24, no. 3, pp. 419–430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. Ruan, M. D. Lai, and J. G. Zhou, “Anticancer effects of Chinese herbal medicine, science or myth?” Journal of Zhejiang University. Science. B, vol. 7, no. 12, pp. 1006–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ruan, T. Ji, W. Yang et al., “Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-κB pathway,” Phytotherapy Research, vol. 22, no. 3, pp. 407–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Mori, T. Kondo, Y. Kamiyama, Y. Kano, and K. Tominaga, “Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer,” Cancer Chemotherapy and Pharmacology, vol. 51, no. 5, pp. 403–406, 2003. View at Scopus
  20. C. S. Cho, Supportive Cancer Care with Chinese Medicine, Springer, Berlin, Germany, 2010.
  21. E. M. Swisher, D. E. Cohn, B. A. Goff et al., “Use of complementary and alternative medicine among women with gynecologic cancers,” Gynecologic Oncology, vol. 84, no. 3, pp. 363–367, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Lin, J. Liu, and Y. Zhang, “Developments in cancer prevention and treatment using traditional Chinese medicine,” Frontiers of Medicine, vol. 5, no. 2, pp. 127–133, 2011.
  23. Z. Guo, X. Jia, J. P. Liu, J. Liao, and Y. Yang, “Herbal medicines for advanced colorectal cancer,” Cochrane Database of Systematic Reviews, vol. 5, Article ID CD004653, 2012.
  24. J. Gao, W. A. Morgan, A. Sanchez-Medina, and O. Corcoran, “The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including upregulation of p53 and Bax in human lung cancer cells,” Toxicology and Applied Pharmacology, vol. 254, no. 3, pp. 221–228, 2011.
  25. K. S. Ahn, G. Sethi, S. Shishodia, B. Sung, J. L. Arbiser, and B. B. Aggarwal, “Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-κB activation pathway,” Molecular Cancer Research, vol. 4, no. 9, pp. 621–633, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Hsieh, W. C. Lin, M. R. Lee et al., “Dang-Gui-Bu-Xai-Tang modulated the immunity of tumor bearing mice,” Immunopharmacology and Immunotoxicology, vol. 25, no. 2, pp. 259–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Hong-Fen, T. Waisman, Y. Maimon, K. Shakhar, E. Rosenne, and S. Ben-Eliyahu, “The effects of a Chinese herb formula, anti-cancer number one (ACNO), on NK cell activity and tumor metastasis in rats,” International Immunopharmacology, vol. 1, no. 11, pp. 1947–1956, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Yang, L. Y. Chien, and C. J. Tai, “Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan,” Journal of Alternative and Complementary Medicine, vol. 14, no. 4, pp. 413–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. C. Lam, C. W. Cheng, H. Peng, C. K. Law, X. Huang, and Z. Bian, “Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey,” Chinese Medicine, vol. 4, article 25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Tas, Z. Ustuner, G. Can et al., “The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients,” Acta Oncologica, vol. 44, no. 2, pp. 161–167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Engdal, A. Steinsbekk, O. Klepp, and O. G. Nilsen, “Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway,” Supportive Care in Cancer, vol. 16, no. 7, pp. 763–769, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Damery, C. Gratus, R. Grieve et al., “The use of herbal medicines by people with cancer: a cross-sectional survey,” British Journal of Cancer, vol. 104, no. 6, pp. 927–933, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Boon, K. Westlake, M. Stewart et al., “Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics,” Urology, vol. 62, no. 5, pp. 849–853, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Molassiotis, P. Fernandez-Ortega, D. Pud et al., “Use of complementary and alternative medicine in cancer patients: a European survey,” Annals of Oncology, vol. 16, no. 4, pp. 655–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Ferro, A. Leis, R. Doll, L. Chiu, M. Chung, and M. C. Barroetavena, “The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients,” Supportive Care in Cancer, vol. 15, no. 8, pp. 985–992, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Richardson, T. Sanders, J. L. Palmer, A. Greisinger, and S. E. Singletary, “Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology,” Journal of Clinical Oncology, vol. 18, no. 13, pp. 2505–2514, 2000. View at Scopus
  37. P. Puataweepong, N. Sutheechet, and P. Ratanamongkol, “A survey of complementary and alternative medicine use in cancer patients treated with radiotherapy in Thailand,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 670408, 6 pages, 2012. View at Publisher · View at Google Scholar
  38. A. Molassiotis and M. Xu, “Quality and safety issues of web-based information about herbal medicines in the treatment of cancer,” Complementary Therapies in Medicine, vol. 12, no. 4, pp. 217–227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Rausch, F. Winegardner, K. M. Kruk et al., “Complementary and alternative medicine: use and disclosure in radiation oncology community practice,” Supportive Care in Cancer, vol. 19, no. 4, pp. 521–529, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Oh, P. Butow, B. Mullan et al., “The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia,” Asia-Pacific Journal of Clinical Oncology, vol. 6, no. 4, pp. 342–349, 2010. View at Publisher · View at Google Scholar · View at Scopus